Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
With Zero Based Budgeting, disciplined budgeting emerges from deliberate dollar allocation to essentials and goals, minimizing waste and boosting consistency.
28,655 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Iran's Kharg Island oil terminal has halted loading for multiple days as President Trump arrives in Beijing. The disr...
As the last Baby Boomers retire, their influence lingers in wages, homes, and boardrooms. This report explains how th...
Investors ditching magnificent group are chasing a fresh AI-led cohort dubbed MANGOS, with Meta, Alphabet and NVIDIA ...
A viral duck became the centerpiece of a commercial shoot outside Azteca Stadium, but FIFA rules prevented him from s...
XRP shows potential for a larger move as price predictions spark optimism, while Shiba Inu burns draw attention and E...
As markets swing in early 2026, three actively-managed ETFs are drawing inflows for steady income and downside protec...
Fastly stock jumps 11% after a strong Q4 2025 report, fueling talk of a true comeback. Yet persistent insider selling...
Pi Network reports rising KYC completion and robust Mainnet migration, as upgrades lay groundwork for smart contracts...
A new survey shows almost 4 in 10 millennials take secret vacations while appearing online, forcing firms to rethink ...
MISMO rolled out FRAME, a governance toolkit for AI in mortgage operations, during its Spring Summit in Louisville. T...
A top economist contends inflation is nearing a turning point, with a single gauge guiding bond yields and mortgage c...